Stroke Unit, Neurology Department, Hospital Universitari Joan XXIII, Tarragona, Spain,
Stroke Unit, Neurology Department, Hospital Universitari Joan XXIII, Tarragona, Spain.
Cerebrovasc Dis. 2020;49(5):550-555. doi: 10.1159/000511063. Epub 2020 Oct 22.
The evolution of the symptomatic intracranial occlusion during transfers from primary stroke centers (PSCs) to comprehensive stroke centers (CSCs) for endovascular treatment (EVT) is not widely known. Our aim was to identify factors related to partial or complete recanalization (REC) at CSC arrival in patients with a documented large vessel occlusion (LVO) in PSC transferred for EVT evaluation to better define the workflow at CSC of this group of patients.
We conducted an observational, multicenter study from a prospective, government-mandated, population-based registry of stroke patients with documented LVO at PSC transferred to CSC for EVT from January 2017 to June 2019. The primary end point was defined as partial or complete REC that precluded EVT at CSC arrival (REC). We evaluated the association between baseline, treatment variables and time intervals with the presence of REC.
From 589 patients, the rate of REC at CSC was 10.5% in all LVO patients transferred from PSC to CSC for EVT evaluation. On univariate analysis, lower PSC-NIHSS (median 12vs.16, p = 0.001), tPA treatment at PSC (13.7 vs. 5.0%; p = 0.001), presence of M2 occlusion on PSC (16.8 vs. 9%; p = 0.023), and clinical improvement at CSC arrival (21.7 vs. 9.6% p = 0.001) were associated with REC at CSC. On multivariate analysis, clinical improvement at CSC arrival (p < 0.001, OR: 5.96 95% CI: 2.5-13.9) and PSC tPA treatment predicted REC (p = 0.003, OR: 4.65, 95% CI: 1.73-12.4).
REC at CSC arrival occurs exceptionally in patients with a documented LVO on PSC. Repeating a second vascular study before EVT would not be necessary in most patients. Despite its modest effect, tPA treatment at PSC was an independent predictor of REC.
原发性卒中中心(PSC)转至综合性卒中中心(CSC)行血管内治疗(EVT)过程中,症状性颅内闭塞的演变情况并不广为人知。我们的目的是确定与 PSC 中记录的大血管闭塞(LVO)患者到达 CSC 时部分或完全再通(REC)相关的因素,以便更好地确定该组患者在 CSC 的工作流程。
我们进行了一项观察性、多中心研究,纳入了 2017 年 1 月至 2019 年 6 月间从 PSC 转至 CSC 行 EVT 评估的记录有 LVO 的卒中患者的前瞻性、政府要求的基于人群的登记处。主要终点定义为到达 CSC 时发生的部分或完全 REC,从而排除了 EVT(REC)。我们评估了基线、治疗变量和时间间隔与 REC 存在之间的关系。
在所有因 LVO 而从 PSC 转至 CSC 行 EVT 评估的患者中,到达 CSC 时 REC 的发生率为 10.5%。在单变量分析中,PSC-NIHSS 评分较低(中位数 12 分比 16 分,p = 0.001)、PSC 时给予 tPA 治疗(13.7%比 5.0%,p = 0.001)、PSC 时存在 M2 闭塞(16.8%比 9%,p = 0.023)以及到达 CSC 时临床改善(21.7%比 9.6%,p = 0.001)与 CSC 时 REC 相关。多变量分析显示,到达 CSC 时的临床改善(p < 0.001,OR:5.96,95%CI:2.5-13.9)和 PSC 时 tPA 治疗预测了 REC(p = 0.003,OR:4.65,95%CI:1.73-12.4)。
PSC 记录的 LVO 患者到达 CSC 时 REC 极为少见。在大多数患者中,在进行 EVT 之前无需重复进行第二次血管研究。尽管其影响较小,但 PSC 时的 tPA 治疗是 REC 的独立预测因素。